MEDISENSE PRECISION PCX POINT OF CARE MANAGEMENT SYSTEM FOR BLOOD GLUCOSE TESTING

Glucose Dehydrogenase, Glucose

ABBOTT LABORATORIES

The following data is part of a premarket notification filed by Abbott Laboratories with the FDA for Medisense Precision Pcx Point Of Care Management System For Blood Glucose Testing.

Pre-market Notification Details

Device IDK022941
510k NumberK022941
Device Name:MEDISENSE PRECISION PCX POINT OF CARE MANAGEMENT SYSTEM FOR BLOOD GLUCOSE TESTING
ClassificationGlucose Dehydrogenase, Glucose
Applicant ABBOTT LABORATORIES 4-A CROSBY DR. Bedford,  MA  01730 -1402
ContactJoseph Magliozzi
CorrespondentJoseph Magliozzi
ABBOTT LABORATORIES 4-A CROSBY DR. Bedford,  MA  01730 -1402
Product CodeLFR  
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-09-03
Decision Date2002-10-28
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.